Contrast enhanced 3D T1w with blood suppression and compressed sensing at 3T - Evaluation of cerebral venous sinus infiltration of meningiomas.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015163

Enrollment

Registered

2018-09-19

Start date

2018-07-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D32.0

Interventions

Group 1: Patients in this study obtain an additional MRI-sequence (3D T1w black blood fast-spin echo sequence using compressed sensing) beside the standard MRI-protocoll. The additional sequence takes

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient send to our radiology department with suspected meningioma adjacent to venous sinus.

Exclusion criteria

Exclusion criteria: contraindication to mri oder mri contrast agent. Pregnancy

Design outcomes

Primary

Measure	Time frame
Radiological agreement of CS-SPACE with combination of 2D TOF and T1w MPRAGE in assessment of venous sinus infiltration	—

Secondary

Measure	Time frame
Radiological agreement of CS-SPACE with combination of 2D TOF and T1w MPRAGE in assessment of tumor infiltration of cortical veins - Compare CS-SPACE with MPRAGE concerning tumor signal and motion artifacts	—

Countries

Germany

Contacts

Public ContactUrs Würtemberger

Universitätsklinikum Freiburg Klinik für Neuroradiologie

urs.wuertemberger@uniklinik-freiburg.de004976127051920

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026